These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7523633)

  • 1. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling.
    Raber J; Bloom FE
    J Neurosci; 1994 Oct; 14(10):6187-95. PubMed ID: 7523633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
    Raber J; Koob GF; Bloom FE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala.
    Raber J; Pich EM; Koob GF; Bloom FE
    Neuroendocrinology; 1994 Mar; 59(3):208-17. PubMed ID: 8159270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation.
    Raber J; Bloom FE
    Neuroscience; 1996 Apr; 71(3):747-59. PubMed ID: 8867047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response.
    Raber J; Koob GF; Bloom FE
    Neurochem Int; 1997; 30(4-5):455-63. PubMed ID: 9106261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
    Hillhouse EW; Milton NG
    J Endocrinol; 1989 Sep; 122(3):719-23. PubMed ID: 2809479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide modulates the release of vasopressin from rat hypothalamic explants.
    Yasin S; Costa A; Trainer P; Windle R; Forsling ML; Grossman A
    Endocrinology; 1993 Sep; 133(3):1466-9. PubMed ID: 7689960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J; Gadek-Michalska A; Głód R; Borycz J
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of norepinephrine and nitric oxide in activities of rat arginine vasopressin neurons in response to immune challenge.
    Xu S; Guo S; Jiang X; Umezawa T; Hisamitsu T
    Neurosci Lett; 2005 Aug; 383(3):231-5. PubMed ID: 15955417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a nitric oxide synthase inhibitor on vasopressin and atrial natriuretic hormone release, thermogenesis and cardiovascular functions in response to interleukin-1 beta in rats.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Funyu T; Abe K
    Tohoku J Exp Med; 1994 Sep; 174(1):59-69. PubMed ID: 7532327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus.
    Rettori V; Gimeno M; Lyson K; McCann SM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11543-6. PubMed ID: 1280829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
    Karanth S; Lyson K; McCann SM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and nitric oxide synthase expression in the vasopressin and corticotrophin-releasing factor systems of the rat hypothalamus.
    González-Hernández T; Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Abreu P; del Mar Pérez-Delgado M; Rancel-Torres N; del Carmen González M
    J Histochem Cytochem; 2006 Apr; 54(4):427-41. PubMed ID: 16322601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
    Hillhouse EW; Milton NG
    J Endocrinol; 1989 Sep; 122(3):713-8. PubMed ID: 2572662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline stimulates somatostatin release from incubated slices of the amygdala and the hypothalamic preoptic area.
    Epelbaum J; Tapia-Arancibia L; Kordon C
    Brain Res; 1981 Jun; 215(1-2):393-7. PubMed ID: 6114780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
    Walker CD; Tankosic P; Tilders FJ; Burlet A
    J Neuroendocrinol; 1997 Jan; 9(1):25-41. PubMed ID: 9023736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats.
    Wahab F; Tazinafo LF; Cárnio EC; Aguila FA; Batalhão ME; Rocha MJ
    Endocrine; 2015 May; 49(1):215-21. PubMed ID: 25338201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice.
    Javadian N; Rahimi N; Javadi-Paydar M; Doustimotlagh AH; Dehpour AR
    Epilepsy Res; 2016 Oct; 126():134-40. PubMed ID: 27497813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.